false
Skip Navigation Links
AOAAM.org
Leadership
Committees
FAQ
Member Search
Mission Statement
Donate
Contact Us
Education
Review Course
Review Course Home
Register
Resources
FAQs
Faculty
Live Q&A Sessions
DEA 8-hour Course
Annual Convention OMED
AOA Addiction Medicine Subspecialty Certification
FAQs
MOUD
The MOUD Training
NP-PA and Advanced MOUD Trainings
PCSS Mentoring
PCSS News
Clinical Tools
Membership
Join Us - Renew
Events
FAQ
Forums
Member Search
AOAAM Fellow
Members Only
Board Members Only
Resources
General News
Position Papers
Journal of Addictive Diseases
Carrying and Administering of Intranasal Naloxone
Marijuana Pocket Card
Opioid Response Network (ORN)
Useful Links
Students
Career Center
Contact Us
Menu
AOAAM.org
Leadership
Committees
FAQ
Member Search
Mission Statement
Donate
Contact Us
Education
Review Course
DEA 8-hour Course
Annual Convention OMED
AOA Addiction Medicine Subspecialty Certification
FAQs
MOUD
The MOUD Training
NP-PA and Advanced MOUD Trainings
PCSS Mentoring
PCSS News
Clinical Tools
Membership
Join Us - Renew
Events
FAQ
Forums
Member Search
AOAAM Fellow
Members Only
Board Members Only
Resources
General News
Position Papers
Journal of Addictive Diseases
Carrying and Administering of Intranasal Naloxone
Marijuana Pocket Card
Opioid Response Network (ORN)
Useful Links
Students
Career Center
Contact Us
Hamburger Menu
Catalog
Calendar
Help & FAQ
Catalog
ORN Fall 2023 - Brixadi (buprenorphine-XR) for the ...
ORN Fall 2023 - Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:
During this lecture participants will learn how to treat patients with opioid use disorder using the newly FDA-approved injectable formulation of buprenorphine, Brixadi.
Learning Objectives:
At the conclusion of this seminar, participants will be able to:
Discuss how to start patients with OUD on Brixadi
Adjust the dose to alleviate opioid withdrawal, suppress cravings and use of opioids
Name typical adverse effects of the medication
Describe how the medication is to be administered and possible sites for injection
Instructions and Claiming CME
Speaker:
Antoine Douaihy, MD
Dr. Douaihy is a Professor of Psychiatry and Medicine, Senior Academic Director of Addiction Medicine Services (AMS) and Addiction Psychiatry Fellowship at Western Psychiatric Hospital of the University of Pittsburgh Medical Center (UPMC), and Co-Director of the Tobacco Treatment Service of UPMC. His areas of clinical and research expertise and interest are substance use disorders (SUDs) and SUDs co occurring with psychiatric disorders in adults and adolescents, psychiatric disorders in individuals with HIV/HCV, smoking cessation and psychosocial approaches, particularly motivational interviewing, and medication trials for co-occurring disorders, opioid and stimulant use disorders. He has a demonstrated record of expertise and experience in SUDs and a well-established record of leadership and expertise in conducting multi-site clinical trials. He has served as Principal Investigator (Pl), Co-I, or a consultant on studies funded by NIAAA, NIDA, NIMH, AFSP, NHLBI, HRSA, SAMHSA, and pharmaceutical industries. He served as a member of the Opioid Addiction Task Force (established by the U.S. District Attorney in Allegheny County) and the opioid addiction and recovery task force at the University of Pittsburgh. He is currently the vice chair of Pittsburgh HIV Commission and a member of the physician work group on medical marijuana at the PA Department of Health.
Summary
Availability:
No future session
Expires on Dec 31, 2024
Cost:
FREE
Credit Offered:
1 AOA Category 1A Credit
×
ORN Fall 2023 - Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder Course List
Create Account
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Fall 2023 - New Approaches to Methamphetamine Addiction and Psychosis
Multiple Credits
FREE
Enduring Activity
Online
(12)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Spring 2024 - ED Treatment of Opioid Use Disorder: Truth, Trends and Treatments
Multiple Credits
FREE
Enduring Activity
Online
(17)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Spring 2024 - Opioid Use Disorder in Youth
Multiple Credits
FREE
Enduring Activity
Online
(21)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Spring 2024 - Exploring the Interface of Cannabis, Cannabinoids, and Opioid Use Disorder: Clinical Insights and Emerging Research
Multiple Credits
FREE
Enduring Activity
Online
(16)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Spring 2024 - Psychostimulant Toxicity
Multiple Credits
FREE
Enduring Activity
Online
(20)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Spring 2024 - Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period
Multiple Credits
FREE
Enduring Activity
Online
(19)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Summer 2024 - Extended-Release Buprenorphine
Multiple Credits
FREE
Enduring Activity
Online
(14)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Summer 2024 - Kratom Consumers in the United States: What clinicians need to know
Multiple Credits
FREE
Enduring Activity
Online
(9)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Summer 2024 - Xylazine Wound Care Clinic and Protocol
Multiple Credits
FREE
Enduring Activity
Online
(15)
Learning Activity Title
Learning Activity Title
Learning Activity Title
ORN Summer 2024 - Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
Multiple Credits
FREE
Enduring Activity
Online
(10)
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English